Test Code HERBN HER2, Breast, Quantitative Immunohistochemistry, Automated, No Reflex
Test Down Notes
Test down effective 10/29/2021 due to an unexpected technical issue related to a testing reagent. There are no alternative testing options available.
Ordering Guidance
For gastroesophageal cancer, order HERGM / HER2, Gastric/Esophageal, Semi-Quantitative Immunohistochemistry, Manual or HERGN / HER2, Gastric/Esophageal, Semi-Quantitative Immunohistochemistry, Manual, No Reflex.
Shipping Instructions
Attach the green pathology address label included in the kit to the outside of the transport container.
Necessary Information
1. Include accompanying pathology report stating the final diagnosis. If not available, a preliminary diagnosis is acceptable only if it refers to invasive or metastatic breast carcinoma.
2. Information regarding fixative used, time to fixation, and duration of fixation is required.
Specimen Required
Supplies: Pathology Packaging Kit (T554)
Specimen Type:
Preferred: A paraffin-embedded tissue block containing breast cancer tissue that has been fixed in 10% neutral buffered formalin within 1 hour from surgical collection time and for a total of 6 to 72 hours and shipped at ambient temperature
Acceptable: 2 unstained sections, containing breast carcinoma, on charged slides cut at 4 microns less than 1 month ago and shipped at ambient temperature. Tissue on the slides should have been fixed in 10% neutral buffered formalin within 1 hour from surgical collection time and for a total of 6 to 72 hours.
Submission Container/Tube: Pathology Packaging Kit (T554)
Collection Instructions: Submit paraffin-embedded invasive or metastatic breast carcinoma tissue.
Additional Information:
1. When ordering this test, the following questions, as stated on the order form or presented electronically, must be answered:
a. "Was specimen fixed in 10% NB formalin w/in 1 hour? Yes, No, or Unknown"
b. "Was specimen fixed in 10% NB formalin 6-72 hours? Yes, No, or Unknown"
c. "Tissue was decalcified? Yes, No, or Unknown."
d. "Tumor type? Primary invasive breast carcinoma or metastatic breast carcinoma."
e. "Tumor classification? Invasive breast carcinoma, metastatic breast carcinoma, or micro-invasive breast carcinoma."
2. According to the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines, HER2 protein immunohistochemical test results are only valid for nondecalcified, paraffin-embedded specimens fixed in 10% neutral buffered formalin within 1 hour from surgical collection time and for a total time of 6 to 72 hours. Under- or overfixation may affect these results.
3. HER2 immunohistochemistry testing on intracystic papillary carcinoma and solid papillary carcinoma, without clearly stating invasive carcinoma, is not appropriate and will be canceled without processing.
4. Paraffin blocks will be returned with final report.
Forms
If not ordering electronically, complete, print, and send an Immunohistochemical (IHC)/In Situ Hybridization (ISH) Stains Request (T763)
Useful For
Determining overexpression of HER2 protein on formalin-fixed, paraffin-embedded tissue sections without a reflex to FISH testing
This FDA-approved test is most frequently used to evaluate HER2 overexpression in breast cancer
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
HERBM | HER Breast Semi Quant IHC Manual | No | No |
Testing Algorithm
Cases that are not able to be scanned for automated analysis due to technical issues will be changed to the manual process for analysis.
Method Name
Ventana Pathway Immunoperoxidase Stain with Automated Quantitative Immunohistochemistry
Reporting Name
HER Breast IHC Automated NO ReflexSpecimen Type
SpecialSpecimen Minimum Volume
Entire block
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Special | Ambient (preferred) | |
Refrigerated |
Reject Due To
No specimen should be rejected.Reference Values
Reported as negative (0, 1+), equivocal (2+), and strongly positive (3+) according to the interpretation guidelines for the FDA-approved Ventana Pathway HER2 (4B5) antibody.
Day(s) Performed
Monday through Friday
Report Available
4 to 6 daysPerforming Laboratory

Test Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88361
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
HERBN | HER Breast IHC Automated NO Reflex | Obsolete |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
70975 | Interpretation | 50595-8 |
70976 | Participated in the Interpretation | No LOINC Needed |
70977 | Report electronically signed by | 19139-5 |
70979 | Material Received | 81178-6 |
MA012 | Fixed in 10% NB formalin w/in 1 hr | 8100-0 |
MA013 | Fixed in 10% NB formalin 6-72 hrs | 8100-0 |
MA014 | Tumor type | 44638-5 |
MA015 | Tumor classification | 21918-8 |
MA047 | Tissue was decalcified | 8100-0 |
71622 | Disclaimer | 62364-5 |
71836 | Case Number | 80398-1 |